Loading…

Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin

Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressi...

Full description

Saved in:
Bibliographic Details
Published in:International journal of nanomedicine 2017-01, Vol.12, p.3433-3446
Main Authors: Kameyama, Kazuhisa, Motoyama, Keiichi, Tanaka, Nao, Yamashita, Yuki, Higashi, Taishi, Arima, Hidetoshi
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123
cites
container_end_page 3446
container_issue
container_start_page 3433
container_title International journal of nanomedicine
container_volume 12
creator Kameyama, Kazuhisa
Motoyama, Keiichi
Tanaka, Nao
Yamashita, Yuki
Higashi, Taishi
Arima, Hidetoshi
description Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.
doi_str_mv 10.2147/IJN.S133482
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6de3764b95d44cbeb4b1ea0ff8ee86a8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6de3764b95d44cbeb4b1ea0ff8ee86a8</doaj_id><sourcerecordid>1899106735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEoqVw4o4icUGqUvwRf12QqorCogoOwBXLdsa7XiXx4jiF_C1-CL8Jl12qltNYM48ejcZvVT3H6IzgVrxeffh49hlT2kryoDrGWMiGIEwf3nkfVU-maYsQE5Krx9URka3ilKDj6ttq7GaXQxzr6Osh5LjbmPXSDNAFk6GrzZhDnoeYalOw65CX-kfIm9rHvswbs9vB2BVugLxZ-ub3r8Ytro8d_MwpjE-rR970Ezw71JPq6-XbLxfvm6tP71YX51eNawXLjZGEKMatNAQDRx0QB4oz74UhBFspgHsqCUJCKgaGgrfIWeKJBGAWE3pSrfbeLpqt3qUwmLToaIL-24hprU3KwfWgeQdU8NYq1rWts2Bbi8Eg74tLciOL683etZttOYODMSfT35Pen4xho9fxWrMWC85vBK8OghS_zzBlPYTJQd-bEeI8aSyVwogLygr68j90G-c0llNpQqjCTDKFC3W6p1yK05TA3y6Dkb7JgC4Z0IcMFPrF3f1v2X-fTv8AOuivyw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2239158591</pqid></control><display><type>article</type><title>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</title><source>Publicly Available Content (ProQuest)</source><source>Taylor &amp; Francis Open Access Journals</source><source>PubMed Central</source><creator>Kameyama, Kazuhisa ; Motoyama, Keiichi ; Tanaka, Nao ; Yamashita, Yuki ; Higashi, Taishi ; Arima, Hidetoshi</creator><creatorcontrib>Kameyama, Kazuhisa ; Motoyama, Keiichi ; Tanaka, Nao ; Yamashita, Yuki ; Higashi, Taishi ; Arima, Hidetoshi</creatorcontrib><description>Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.</description><identifier>ISSN: 1178-2013</identifier><identifier>ISSN: 1176-9114</identifier><identifier>EISSN: 1178-2013</identifier><identifier>DOI: 10.2147/IJN.S133482</identifier><identifier>PMID: 28496320</identifier><language>eng</language><publisher>New Zealand: Taylor &amp; Francis Ltd</publisher><subject>Adenosine triphosphate ; Angiogenesis ; Animals ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis ; Autophagy ; Autophagy - drug effects ; beta-Cyclodextrins - chemistry ; beta-Cyclodextrins - pharmacology ; Cancer ; Cell Survival - drug effects ; Cervical cancer ; Clinical trials ; folate receptor ; Folate Receptor 1 - metabolism ; Folic Acid - chemistry ; Folic Acid - pharmacology ; Graduate studies ; Humans ; KB Cells - drug effects ; Kinases ; Life sciences ; Male ; methyl--cyclodextrin ; Mice ; Mice, Inbred BALB C ; Mitochondria ; Mitochondrial Degradation - drug effects ; mitophagy ; Molecular Targeted Therapy - methods ; Original Research ; Protein Kinases - metabolism ; Reactive oxygen species ; tumor targeting ; Tumors ; Vitamin B ; Xenograft Model Antitumor Assays</subject><ispartof>International journal of nanomedicine, 2017-01, Vol.12, p.3433-3446</ispartof><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Kameyama et al. This work is published and licensed by Dove Medical Press Limited 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2239158591/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2239158591?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28496320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kameyama, Kazuhisa</creatorcontrib><creatorcontrib>Motoyama, Keiichi</creatorcontrib><creatorcontrib>Tanaka, Nao</creatorcontrib><creatorcontrib>Yamashita, Yuki</creatorcontrib><creatorcontrib>Higashi, Taishi</creatorcontrib><creatorcontrib>Arima, Hidetoshi</creatorcontrib><title>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</title><title>International journal of nanomedicine</title><addtitle>Int J Nanomedicine</addtitle><description>Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.</description><subject>Adenosine triphosphate</subject><subject>Angiogenesis</subject><subject>Animals</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>beta-Cyclodextrins - chemistry</subject><subject>beta-Cyclodextrins - pharmacology</subject><subject>Cancer</subject><subject>Cell Survival - drug effects</subject><subject>Cervical cancer</subject><subject>Clinical trials</subject><subject>folate receptor</subject><subject>Folate Receptor 1 - metabolism</subject><subject>Folic Acid - chemistry</subject><subject>Folic Acid - pharmacology</subject><subject>Graduate studies</subject><subject>Humans</subject><subject>KB Cells - drug effects</subject><subject>Kinases</subject><subject>Life sciences</subject><subject>Male</subject><subject>methyl--cyclodextrin</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mitochondria</subject><subject>Mitochondrial Degradation - drug effects</subject><subject>mitophagy</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Original Research</subject><subject>Protein Kinases - metabolism</subject><subject>Reactive oxygen species</subject><subject>tumor targeting</subject><subject>Tumors</subject><subject>Vitamin B</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1178-2013</issn><issn>1176-9114</issn><issn>1178-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkk1v1DAQhiMEoqVw4o4icUGqUvwRf12QqorCogoOwBXLdsa7XiXx4jiF_C1-CL8Jl12qltNYM48ejcZvVT3H6IzgVrxeffh49hlT2kryoDrGWMiGIEwf3nkfVU-maYsQE5Krx9URka3ilKDj6ttq7GaXQxzr6Osh5LjbmPXSDNAFk6GrzZhDnoeYalOw65CX-kfIm9rHvswbs9vB2BVugLxZ-ub3r8Ytro8d_MwpjE-rR970Ezw71JPq6-XbLxfvm6tP71YX51eNawXLjZGEKMatNAQDRx0QB4oz74UhBFspgHsqCUJCKgaGgrfIWeKJBGAWE3pSrfbeLpqt3qUwmLToaIL-24hprU3KwfWgeQdU8NYq1rWts2Bbi8Eg74tLciOL683etZttOYODMSfT35Pen4xho9fxWrMWC85vBK8OghS_zzBlPYTJQd-bEeI8aSyVwogLygr68j90G-c0llNpQqjCTDKFC3W6p1yK05TA3y6Dkb7JgC4Z0IcMFPrF3f1v2X-fTv8AOuivyw</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Kameyama, Kazuhisa</creator><creator>Motoyama, Keiichi</creator><creator>Tanaka, Nao</creator><creator>Yamashita, Yuki</creator><creator>Higashi, Taishi</creator><creator>Arima, Hidetoshi</creator><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</title><author>Kameyama, Kazuhisa ; Motoyama, Keiichi ; Tanaka, Nao ; Yamashita, Yuki ; Higashi, Taishi ; Arima, Hidetoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenosine triphosphate</topic><topic>Angiogenesis</topic><topic>Animals</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>beta-Cyclodextrins - chemistry</topic><topic>beta-Cyclodextrins - pharmacology</topic><topic>Cancer</topic><topic>Cell Survival - drug effects</topic><topic>Cervical cancer</topic><topic>Clinical trials</topic><topic>folate receptor</topic><topic>Folate Receptor 1 - metabolism</topic><topic>Folic Acid - chemistry</topic><topic>Folic Acid - pharmacology</topic><topic>Graduate studies</topic><topic>Humans</topic><topic>KB Cells - drug effects</topic><topic>Kinases</topic><topic>Life sciences</topic><topic>Male</topic><topic>methyl--cyclodextrin</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mitochondria</topic><topic>Mitochondrial Degradation - drug effects</topic><topic>mitophagy</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Original Research</topic><topic>Protein Kinases - metabolism</topic><topic>Reactive oxygen species</topic><topic>tumor targeting</topic><topic>Tumors</topic><topic>Vitamin B</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kameyama, Kazuhisa</creatorcontrib><creatorcontrib>Motoyama, Keiichi</creatorcontrib><creatorcontrib>Tanaka, Nao</creatorcontrib><creatorcontrib>Yamashita, Yuki</creatorcontrib><creatorcontrib>Higashi, Taishi</creatorcontrib><creatorcontrib>Arima, Hidetoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kameyama, Kazuhisa</au><au>Motoyama, Keiichi</au><au>Tanaka, Nao</au><au>Yamashita, Yuki</au><au>Higashi, Taishi</au><au>Arima, Hidetoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</atitle><jtitle>International journal of nanomedicine</jtitle><addtitle>Int J Nanomedicine</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>12</volume><spage>3433</spage><epage>3446</epage><pages>3433-3446</pages><issn>1178-2013</issn><issn>1176-9114</issn><eissn>1178-2013</eissn><abstract>Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.</abstract><cop>New Zealand</cop><pub>Taylor &amp; Francis Ltd</pub><pmid>28496320</pmid><doi>10.2147/IJN.S133482</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-2013
ispartof International journal of nanomedicine, 2017-01, Vol.12, p.3433-3446
issn 1178-2013
1176-9114
1178-2013
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6de3764b95d44cbeb4b1ea0ff8ee86a8
source Publicly Available Content (ProQuest); Taylor & Francis Open Access Journals; PubMed Central
subjects Adenosine triphosphate
Angiogenesis
Animals
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Apoptosis
Autophagy
Autophagy - drug effects
beta-Cyclodextrins - chemistry
beta-Cyclodextrins - pharmacology
Cancer
Cell Survival - drug effects
Cervical cancer
Clinical trials
folate receptor
Folate Receptor 1 - metabolism
Folic Acid - chemistry
Folic Acid - pharmacology
Graduate studies
Humans
KB Cells - drug effects
Kinases
Life sciences
Male
methyl--cyclodextrin
Mice
Mice, Inbred BALB C
Mitochondria
Mitochondrial Degradation - drug effects
mitophagy
Molecular Targeted Therapy - methods
Original Research
Protein Kinases - metabolism
Reactive oxygen species
tumor targeting
Tumors
Vitamin B
Xenograft Model Antitumor Assays
title Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A20%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Induction%20of%20mitophagy-mediated%20antitumor%20activity%20with%20folate-appended%20methyl-%CE%B2-cyclodextrin&rft.jtitle=International%20journal%20of%20nanomedicine&rft.au=Kameyama,%20Kazuhisa&rft.date=2017-01-01&rft.volume=12&rft.spage=3433&rft.epage=3446&rft.pages=3433-3446&rft.issn=1178-2013&rft.eissn=1178-2013&rft_id=info:doi/10.2147/IJN.S133482&rft_dat=%3Cproquest_doaj_%3E1899106735%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2239158591&rft_id=info:pmid/28496320&rfr_iscdi=true